Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-052034

Chief Executive Officer sold 4,400 shares at an average $15.02 ($66,066)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2017-09-06 Sale −2,200 $15.05 $33,110 439,578 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2017-09-07 Sale −2,200 $14.98 $32,956 437,378 I: show line 2 in the form
Open-market sales · 4,400 sh · avg $15.02 · $66,066
Loading xslF345X03/doc4.xml…